Talk not ready, need approval first!
Toggle navigation
Home
Feed
Channels
Profile
Home
Feed
Channels
Profile
Medspoke's Talks
Medspoke
Medspoke
Blood
Published October 5, 2026
STAG2 mutations fine-tune the ALK-driven oncogenic program in ALK-positive anaplastic large cell ...
October 6, 2026
Medspoke
Medspoke
Blood
Published October 5, 2026
00:00
--:--
Mosunetuzumab and Polatuzumab Vedotin as First-line Treatment for Large B Cell Lymphoma in Older ...
October 6, 2026
Share
Mosunetuzumab and Polatuzumab Vedotin as First-line Treatment for Large B Cell Lymphoma in Older Unfit or Frail Patients.
https://www.medspoke.co/channel_journal?id=683&tap_id=15130
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
Medspoke
Medspoke
Journal of the American Academy of Dermatology (JAAD)
Published October 5, 2026
Artificial Intelligence Techniques for Diagnosing and Quantifying Vitiligo: A Systematic Review a...
October 6, 2026
Why are you reporting this TALK?